Global research publisher and information analytics provider optimises contract lifecycle and reduces contract generation time from days to hours London, UK – 24th March, 2022 – Conga, the global leader in commercial operations transformation, today announced that Elsevier, part of the RELX Group, and a global research publishing and information analytics provider, has implemented the… Read More »
Executives from Coinbase, Cooley LLP, Marsh, State Street and others join industry leading MPC product and tech providers to explore the game changing benefits of MPC in fintech San Francisco, March 7, 2022 – Experts in blockchain, finance, the digital asset eco-system and Multi-Party Computation (MPC) will take to the stage during the MPC Digital… Read More »
We welcome comments, which users can leave at the end of any of our systematic story reviews or at the end of any of our blog posts. But before leaving a comment, please review these notes about our policy. You are responsible for any comments you leave on this site. This site is primarily a… Read More »
May 1, 2021 Approval is based on demonstrated reduction in liver iron concentration Expanded indications for patients with sickle cell disease or other anemias, as well as thalassemia – BOSTON, May 1, 2021 /PRNewswire/ — Chiesi Global Rare Diseases, a business unit of Chiesi Farmaceutici S.p.A., an international research-focused healthcare Group (Chiesi Group), announced today… Read More »
The World Health Organization today declared the coronavirus a Public Health Emergency of International Concern. In the U.S., the Centers for Disease Control and Prevention today confirmed its first case of the spread of the coronavirus by person-to-person contact, bringing the total number of cases in this country to six. In all of the other… Read More »
How the Montreal Protocol has slowed the rate of global warming New research by Australian scientists has shown how the Montreal Protocol not only saved the ozone layer but has also slowed the rate of global warming by as much as 25%. Video: The Australian Academy of Science How the Montreal Protocol has slowed the… Read More »
Dive Brief: The Food and Drug Administration on Monday approved Global Blood Therapeutics’ sickle cell drug voxelotor, completing a rapid review that took the regulator about 90 days. The accelerated OK is conditional on the biotech completing a study to confirm the rise in hemoglobin measured in trials so far yields clinical benefit. Global Blood… Read More »